Patient's preference regarding the option of performing unselective liver biopsy following methotrexate treatment in rheumatoid arthritis.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Clinical and Experimental Rheumatology

• Publication date

  1994-11-01

• Fields of study

  Medicine

• Identifiers
  PMID 7895396
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liver biopsies in patients with rheumatoid arthritis receiving methotrexate: where are we going?

  1992cited by this paper
• A Bedside Decision Instrument To Elicit a Patient's Preference Concerning Adjuvant Chemotherapy for Breast Cancer

  1992cited by this paper
• Adverse experience with methotrexate during 176 weeks of a longterm prospective trial in patients with rheumatoid arthritis.

  1990cited by this paper
• Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts.

  1990cited by this paper
• What do patients and rheumatologists regard as an 'acceptable' risk in the treatment of rheumatic disease?

  1990cited by this paper
• Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate.

  1989cited by this paper
• Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate.

  1988cited by this paper
• Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis.

  1988cited by this paper
• Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis.

  1988cited by this paper
• A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Update after a mean of fifty-three months.

  1988cited by this paper
• The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis.

  1986cited by this paper
• Willingness to pay and accept risks to cure chronic disease.

  1986cited by this paper

• Advances in Shared Decision Making in Brazil: The role of patient autonomy in curriculum reform, health system and clinical care.

  2024cites this paper
• Decision aid for prostate cancer screening in Brazil

  2022cites this paper
• Ferramenta de apoio à decisão sobre o rastreamento do câncer de próstata no Brasil

  2022cites this paper
• Advances in Shared Decision Making in Brazil: The role of patient autonomy in curriculum reform, health system and clinical care.

  2022cites this paper
• Shared decision making in Brazil: history and current discussion.

  2011cites this paper
• The use of a decision board to elicit Brazilian patients' and physicians' preferences for treatment: the case of lupus nephritis.

  2011cites this paper
• Methotrexate hepatotoxicity.

  1997cites this paper